HA : RHAMM interaction is also reported to activate the RHO-ROCK signaling pathway in prostate cancer cells, ultimately leading to the phosphorylation of translation initiation factor eIF4E, an observation that was associated with treatment resistance (65). This evidence concerns the gene HMMR and prostate cancer.